burger menu open
search-icon
Search Tile About us Search Tile Newsroom
Search Tile Careers Search Tile Investor Relations
Search Tile Sustainability
Loading...

Why invest in Redcare?

News

31/10/2023
Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year.
Go
Financial News
05/10/2023
Redcare Pharmacy continues to successfully grow fast in all its markets.
Go
Financial News
01/08/2023
Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.
Go
Financial News
View all

Publications

File icon
Q3 statement / Q3 financial report 2023
Quarterly Reports 31/10/2023 10.9 MB
Download
File icon
Half-yearly financial report 2023
Quarterly Reports 01/08/2023 10.94 MB
Download
View all

Calendar

05 Mar
Annual Report 2023
Add to calendar
17 Apr
Annual General Meeting
Add to calendar
View all

Financial by the numbers

0 $

Lorem ipsum

0 $

Lorem ipsum

0 $

Lorem ipsum

0 $

Lorem ipsum

0 $

Lorem ipsum

Facts & Figures as of 2022

Redcare in numbers

Data
9,3   m

Active Customers
(5-fold increase since 2016)

Data
EUR 1,2   bn

Sales
(7-fold increase since 2016)

Data
> 23   m

Orders
(6-fold increase since 2016)

Net Promoter Score (NPS)

Avg. value for 2022

Fact Sheet

Download

Investment Case

Download

ESG

Discover our approach

Stay up to date

If you want to receive news from Redcare Pharmacy, such as corporate news or financial reports, please register below.

Receive Notifications

Want to know more?

Get in touch and send us an email.

Do you have any feedback or questions?
We are happy to hear from you.

headset-icon

Monica Ambrosi

Associate Director, Investor Relations

investors@redcare-pharmacy.com